CS logo
small CS logo
Queen Mary Hospital; Surgery

Hong Kong, Hong Kong
Hospital in Hong Kong
Queen Mary Hospital Main Block, Pok Fu Lam Rd, Pok Fu Lam
1,711 Beds

About Queen Mary Hospital; Surgery


The Queen Mary Hospital, located in Pok Fu Lam on Hong Kong Island of Hong Kong, is the public district general hospital and teaching hospital of the Faculty of Dentistry and Li Ka Shing Faculty of Medicine of the University of Hong Kong. It has 1,706 beds.
There are 1,711 beds in Queen Mary Hospital; Surgery.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Total Rows: 1

Clinical Trials at Queen Mary Hospital; Surgery


During the past decade, Queen Mary Hospital; Surgery conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
2013-04-03
2025-04-03
Active, not recruiting
1,487
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital; Surgery" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 6Hoffmann-La Roche: 6

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1German Breast Group: 1German Breast Group: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Clinical Trials Conditions at Queen Mary Hospital; Surgery


According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital; Surgery" are "Breast Cancer" (5 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Queen Mary Hospital; Surgery" in a lesser frequency.

Clinical Trials Intervention Types at Queen Mary Hospital; Surgery


Most popular intervention types in "Queen Mary Hospital; Surgery" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Trastuzumab" (3 trials), "5-Fluorouracil" (2 trials), "Capecitabine" (2 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Queen Mary Hospital; Surgery


The vast majority of trials in "Queen Mary Hospital; Surgery" are 4 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Queen Mary Hospital; Surgery


Currently, there are NaN active trials in "Queen Mary Hospital; Surgery". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Queen Mary Hospital; Surgery, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Mary Hospital; Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1